Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 858237, 9 pages
http://dx.doi.org/10.1155/2014/858237
Research Article

Urinary Trypsin Inhibitor Ameliorates Seawater Immersion-Induced Intestinal Mucosa Injury via Antioxidation, Modulation of NF-B Activity, and Its Related Cytokines in Rats with Open Abdominal Injury

1Department of General Surgery, The 175th Hospital of PLA, Southeast Hospital Affiliated to Xiamen University, No. 269 Zhanghua Middle Road, Zhangzhou, Fujian 363000, China
2The First College of Clinical Medical Science, China Three Gorges University, No. 183 Yiling Road, Yichang, Hubei 443000, China

Received 16 April 2014; Accepted 25 July 2014; Published 21 August 2014

Academic Editor: Paolo Gionchetti

Copyright © 2014 Xing Jian Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Aranow and M. P. Fink, “Determinants of intestinal barrier failure in critical illness,” British Journal of Anaesthesia, vol. 77, no. 1, pp. 71–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Swank and E. A. Deitch, “Role of the gut in multiple organ failure: bacterial translocation and permeability changes,” World Journal of Surgery, vol. 20, no. 4, pp. 411–417, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Doig, L. R. Sutherland, J. D. Sandham, G. H. Fick, and M. Verhoef, “Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 2, pp. 444–451, 1998. View at Publisher · View at Google Scholar
  4. P. L. Faries, R. J. Simon, A. T. Martella, M. J. Lee, and G. W. Machiedo, “Intestinal permeability correlates with severity of injury in trauma patients,” Journal of Trauma, vol. 44, no. 6, pp. 1031–1036, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Li, S. S. Wu, T. Sun, C. Q. Liu, J. Pu et al., “Effect of seawater immersion on intestinal barrier following open abdominal injury in dogs,” Chinese Journal of Nautical Medicine and Hyperbaric Medicine, vol. 17, no. 5, pp. 261–265, 2010. View at Google Scholar
  6. Z. W. Wang, Y. A. Wu, X. T. Liu et al., “Changes of gut mucosal barrier in rats with open celiac seawater immersion wounds,” Chinese Journal Of Nautical Medicine and Hyperbaric Medicine, vol. 10, no. 3, pp. 129–132, 2003. View at Google Scholar
  7. Y. Wang, E. Lu, J. Yu, H. Li, D. Wang, and Z. Zhou, “Hemodynamic and pathologic changes in open abdominal wound after seawater immersion in dog,” Zhonghua Wai Ke Za Zhi, vol. 38, no. 9, pp. 700–702, 2000. View at Google Scholar · View at Scopus
  8. Z. H. Han, J. Y. Yu, M. Hu et al., “Effect of seawater immersion on the NF-κB, IκB and TLR4 expression in small intestinal tissues in rats with abdominal open injury,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 17, pp. 893–897, 2013. View at Google Scholar
  9. Y. H. Wang, G. Liu, J. Y. Yu, Y. H. Meng, and X. L. Zhang, “Relationship of nuclear factor kappa B and inflammatory response syndrome caused by abdominal injury immersion,” Journal of Trauma Surgery, vol. 11, no. 2, pp. 163–165, 2009. View at Google Scholar
  10. Y. A. Wu, Z. W. Wang, X. T. Liu et al., “Effect of seawater immersion on plasma MDA and SOD levels in dogs with open celiac wound,” Chinese Journal of Nautical Medicine and Hyperbaric Medicine, vol. 8, no. 3, pp. 148–150, 2001. View at Google Scholar
  11. M. Muramatu, S. Mori, Y. Matsuzawa, Y. Horiguchi, Y. Nakanishi, and M. Tanaka, “Purification and characterization of urinary trypsin inhibitor, UTI 68, from normal human urine, and its cleavage by human uropepsin,” The Journal of Biochemistry, vol. 88, no. 5, pp. 1317–1329, 1980. View at Google Scholar · View at Scopus
  12. T. Tani, H. Abe, Y. Endo, K. Hanasawa, and M. Kodama, “Effects of a urinary trypsin inhibitor on acute circulatory insufficiency after surgical operation,” American Journal of Surgery, vol. 175, no. 2, pp. 142–145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Tani, M. Otsuki, H. Itoh, T. Nakamura, and M. Fujii, “The protective effect of the trypsin inhibitor urinastatin on cerulean–induced acute pancreatitis in rats,” Pancreas, vol. 3, no. 4, pp. 471–476, 1988. View at Google Scholar
  14. M. Rui, Y. Duan, X. Zhang, H. Wang, and D. Wang, “Urinary trypsin inhibitor attenuates seawater-induced acute lung injury by influencing the activities of nuclear factor-κB and its related inflammatory mediators,” Respiration, vol. 83, no. 4, pp. 335–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. J. Wu, Q. Ling, X. H. Zhou, Y. Wang, H. Y. Xie, and S. S. Zheng, “Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation,” Hepatobiliary & Pancreatic Diseases International, vol. 8, no. 1, pp. 53–58, 2010. View at Google Scholar
  16. R. Tanaka, M. Fujita, R. Tsuruta et al., “Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats,” Inflammation Research, vol. 59, no. 8, pp. 597–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Huang, F. Wang, Y. Wang, J. Hou, J. Li, and X. Deng, “Ulinastatin improves survival of septic mice by suppressing inflammatory response and lymphocyte apoptosis,” Journal of Surgical Research, vol. 182, no. 2, pp. 296–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Hu, Y. Duan, Y. Li, and Z. Xue, “Early responses of VEGF during acute lung injury induced by seawater immersion after open chest trauma,” Respiration, vol. 79, no. 6, pp. 490–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Rosenkranz, S. Schmaldienst, K. M. Stuhlmeier, W. Chen, W. Knapp, and G. J. Zlabinger, “A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate,” Journal of Immunological Methods, vol. 156, no. 1, pp. 39–45, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. C. H. Hang, J. X. Shi, J. S. Li, and W. Q. Li, “Expressions of intestinal NF-kappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats,” Journal of Surgical Research, vol. 123, no. 2, pp. 188–193, 2005. View at Google Scholar
  21. C. J. Chiu, A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd, “Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal,” Archives of Surgery, vol. 101, no. 4, pp. 478–483, 1970. View at Google Scholar
  22. A. L. Dougherty, C. R. Mohrle, M. R. Galarneau, S. I. Woodruff, J. L. Dye, and K. H. Quinn, “Battlefield extremity injuries in Operation Iraqi Freedom,” Injury, vol. 40, no. 7, pp. 772–777, 2009. View at Publisher · View at Google Scholar
  23. M. Pidwirny, “Physical and chemical charac-teristics of seawater,” in Fundamentals of Physical Geography, M. Pidwirny, Ed., 2nd edition, 2008, http://www.physicalgeography.net/fundamentals/contents.html. View at Google Scholar
  24. K. R. Groschwitz and S. P. Hogan, “Intestinal barrier function: molecular regulation and disease pathogenesis,” Journal of Allergy and Clinical Immunology, vol. 124, no. 1, pp. 3–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. A. Deitch, “The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure,” Archives of Surgery, vol. 125, no. 3, pp. 403–404, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kanai, T. Ishiwata, T. Kobayashi et al., “Ulinastatin , a urinary trypsin inhibitor, for the initial treatment of patients with kawasaki disease a retrospective study,” Circulation, vol. 124, no. 25, pp. 2822–2828, 2011. View at Google Scholar
  27. K. Inoue, H. Takano, A. Shimada, R. Yanagisawa, and M. Sakurai, “Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide,” Molecular Pharmacology, vol. 67, no. 3, pp. 673–680, 2005. View at Google Scholar
  28. Y. Okuhama, M. Shiraishi, T. Higa et al., “Protective effects of ulinastatin against ischemia-reperfusion injury,” Journal of Surgical Research, vol. 82, no. 1, pp. 34–42, 1999. View at Publisher · View at Google Scholar
  29. M. R. W. Grotz, E. A. Deitch, J. Ding, D. Xu, Q. Huang, and G. Regel, “Intestinal cytokine response after gut ischemia: role of gut barrier failure,” Annals of Surgery, vol. 229, no. 4, pp. 478–486, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Yamamoto, M. Tanabe, G. Wakabayashi, M. Shimazu, K. Matsumoto, and M. Kitajima, “The role of tumor necrosis factor-α and interleukin-1β in ischemia-reperfusion injury of the rat small intestine,” Journal of Surgical Research, vol. 99, no. 1, pp. 134–141, 2001. View at Publisher · View at Google Scholar
  31. D. D. Henninger, J. Panés, M. Eppihimer et al., “Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse,” The Journal of Immunology, vol. 158, no. 4, pp. 1825–1832, 1997. View at Google Scholar
  32. M. R. Grotz, E. A. Deitch, J. Ding et al., “Intestinal cytokine response after gut ischemia: role of gut barrier failure,” Annals of Surgery, vol. 229, no. 4, pp. 478–486, 1999. View at Google Scholar
  33. T. Kimura, Y. Fujiyama, M. Sasaki et al., “The role of mucosal mast cell degranulation and free-radical generation in intestinal ischaemia-reperfusion injury in rats,” European Journal of Gastroenterology and Hepatology, vol. 10, no. 8, pp. 659–666, 1998. View at Google Scholar · View at Scopus
  34. D. L. Carden and D. N. Granger, “Pathophysiology of ischemia-reperfusion injury,” The Journal of Pathology, vol. 190, no. 3, pp. 255–266, 2000. View at Google Scholar
  35. M. Karabeyoğlu, B. Unal, B. Bozkurt, I. Dolapçi, and A. Bilgihan, “The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury,” Journal of Surgical Research, vol. 144, no. 1, pp. 59–63, 2008. View at Google Scholar
  36. B. Hoesel and J. A. Schmid, “The complexity of NF-κB signaling in inflammation and cancer,” Molecular Cancer, vol. 12, no. 1, article 86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Caamaño and C. A. Hunter, “NF- kappaB family of transcription factors: central regulators of innate and adaptive immune functions,” Clinical Microbiology Reviews, vol. 15, no. 3, pp. 414–429, 2002. View at Publisher · View at Google Scholar
  38. P. P. Tak and G. S. Firestein, “NF-kappaB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Google Scholar
  39. E. Abraham, “NF-kappaB activation,” Critical Care Medicine, vol. 28, no. 4, supplement, pp. N100–N104, 2000. View at Google Scholar
  40. T. Liu, C. Andrew Hu, Y. Chen, A. Stern, and J. Cheng, “Differentiation status modulates transcription factor NF-κB activity in unstimulated human hepatocellular carcinoma cell lines,” Cancer Letters, vol. 151, no. 1, pp. 49–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Yamaguchi, H. Ohshiro, Y. Nagao et al., “Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion,” Journal of Surgical Research, vol. 94, no. 2, pp. 107–115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. J. Wu, Q. Ling, X. H. Zhou et al., “Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation,” Hepatobiliary & Pancreatic Diseases International, vol. 8, no. 1, pp. 53–58, 2009. View at Google Scholar
  43. M. Rui, Y. Duan, X. Zhang, H. Wang, and D. Wang, “Urinary trypsin inhibitor attenuates seawater-induced acute lung injury by influencing the activities of nuclear factor-κB and its related inflammatory mediators,” Respiration, vol. 83, no. 4, pp. 335–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Okaya and A. B. Lentsch, “Hepatic expression of S32A/S36A IκBα does not reduce postischemic liver injury,” Journal of Surgical Research, vol. 124, no. 2, pp. 244–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. D. Joseph, E. S. Yeh, K. I. Swenson, and A. R. Means, “The peptidyl-prolyl isomerase Pin1,” Progress in cell cycle research, vol. 5, pp. 477–487, 2003. View at Google Scholar · View at Scopus